The influence of esters and carboxylic acids as the N-substituent of opioids. Part 1: Benzomorphans
- PMID: 17962026
- PMCID: PMC2254757
- DOI: 10.1016/j.bmc.2007.10.030
The influence of esters and carboxylic acids as the N-substituent of opioids. Part 1: Benzomorphans
Abstract
To investigate the effects of carboxylic ester and acid moieties as the N-substituent of opioids, a short series of racemic N-substituted normetazocines was prepared. The introduction of both groups as the normetazocine N-substituent produced compounds which displayed low potency in vitro and in vivo, with the esters displaying the greater activity. The pharmacology of the compounds is discussed with implications resulting from potential in vivo metabolic hydrolysis.
Figures
Similar articles
-
Evaluation of N-substituent structural variations in opioid receptor profile of LP1.Bioorg Med Chem. 2016 Jun 15;24(12):2832-42. doi: 10.1016/j.bmc.2016.05.005. Epub 2016 May 5. Bioorg Med Chem. 2016. PMID: 27234885
-
Benzomorphan scaffold for opioid analgesics and pharmacological tools development: A comprehensive review.Eur J Med Chem. 2018 Mar 25;148:410-422. doi: 10.1016/j.ejmech.2018.02.046. Epub 2018 Feb 17. Eur J Med Chem. 2018. PMID: 29477074 Review.
-
Potential long acting opiate antagonists: preparation, pharmacological activity, and opiate-receptor binding of N-substituted 2'-hydroxy-5-methyl-9 alpha-propyl-6,7-benzomorphans.J Pharm Sci. 1977 Feb;66(2):193-7. doi: 10.1002/jps.2600660215. J Pharm Sci. 1977. PMID: 190376
-
N-(trifluoromethyl)benzyl substituted N-normetazocines and N-norketobemidones.Bioorg Med Chem. 2003 Jan 2;11(1):31-3. doi: 10.1016/s0968-0896(02)00435-2. Bioorg Med Chem. 2003. PMID: 12467704
-
Benzomorphan skeleton, a versatile scaffold for different targets: A comprehensive review.Eur J Med Chem. 2018 Jul 15;155:492-502. doi: 10.1016/j.ejmech.2018.06.017. Epub 2018 Jun 7. Eur J Med Chem. 2018. PMID: 29908442 Review.
Cited by
-
Synthesis and Structure-Activity Relationships of LP1 Derivatives: N-Methyl-N-phenylethylamino Analogues as Novel MOR Agonists.Molecules. 2018 Mar 16;23(3):677. doi: 10.3390/molecules23030677. Molecules. 2018. PMID: 29547588 Free PMC article.
-
New Insights into the Opioid Analgesic Profile of cis-(-)-N-Normetazocine-derived Ligands.Molecules. 2023 Jun 17;28(12):4827. doi: 10.3390/molecules28124827. Molecules. 2023. PMID: 37375382 Free PMC article.
-
Design, Synthesis, and Evaluation of Novel (-)-cis-N-Normetazocine Derivatives: In Vitro and Molecular Modeling Insights.Chem Biol Drug Des. 2024 Dec;104(6):e70037. doi: 10.1111/cbdd.70037. Chem Biol Drug Des. 2024. PMID: 39726303 Free PMC article.
-
Synthesis and Structure-Activity Relationships of (-)-cis-N-Normetazocine-Based LP1 Derivatives.Pharmaceuticals (Basel). 2018 May 5;11(2):40. doi: 10.3390/ph11020040. Pharmaceuticals (Basel). 2018. PMID: 29734749 Free PMC article.
References
-
- Casy AF, Parfitt RT. Opioid Analgesics. New York and London: Plenum Press; 1986.
-
- May EL, Jacobson AE, Mattson MV, Coop A, Aceto MD, Bowman ER, John R, Traynor JR, Woods JH, Harris LS. Med Chem Res. 1998;8:311.
-
- May EL, Coop A, Woods JH, Aceto MD, Bowman ER, Harris LS, Traynor JR. Bioorg Med Chem. 2003;11:31. - PubMed
-
- Feldman PL, James MK, Brackeen MF, Bilotta JM, Schuster SV, Lahey AP, Lutz MW, Johnson MR, Leighton HJ. J Med Chem. 1991;34:2202. - PubMed
-
- Albertson NF, McKay FC. J Med Chem. 1977;20:602. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Chemical Information